The objective of this grant is to identify the molecular defect responsible for the temperature-sensitive RNA splicing phenotype of the ts110 Moloney murine sarcoma virus (Mo-MuSV). The viral genome (4.0 kb viral RNA) has suitable splice donor and acceptor sites that are used to generate a 3.5 kb viral mRNA which is translated to produce the transforming protein termed P85/gag- mos. This splicing reaction occurs readily at 28 degrees C in cells but not at 39 degrees C. There are two possible explanations for this viral conditional defect: First, the 4.0 kb viral RNA may have a structural alteration that does not allow itself to be spliced at restrictive temperatures; second, a heat-labile viral protein may participate in the splicing reaction; at restrictive temperatures it might block the splicing reaction. The following specific aims will be addressed to shed light on these two possibilities: 1) characterize viral RNA-containing nuclear complexes (spliceosomes) present in extracts of cells infected with ts110, its wild-type revertant and parental MuSV-124; 2) test ability of these spliceosome complexes to allow splicing; 3) construct MuSV DNA structures containing ts110 splicing elements capable of generating -600 nt 32/P-labeled pre-mRNAs in vitro with SP6 polymerase; and 4) test such pre-mRNAs for splicing in vitro; 5) analyze the structure of 32/P-labeled pre- mRNA intermediates and products in such a splicing system; 6) determine whether their splicing is ts in vitro; 7) if length intron in order to confer ts splicing phenotype; 8) study in vitro splicing with labeled chimeric ts110-adenovirus late pre-mRNA constructs to identify sequence elements involved in the conditional splicing defect; 9) Investigate the role of viral gene products in the splicing of 32/P-labeled pre-mRNA in nuclear extracts prepared from ts110 infected cells maintained at permissive and restrictive temperatures; 10) Test in vivo splicing by using full length ts110- like DNA, but with a short intron.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Experimental Virology Study Section (EVR)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas MD Anderson Cancer Center
United States
Zip Code
Meyer, M K; Nash, M A; Arlinghaus, R B (1995) Identification of a new viral protein containing CAp30 and NCp10 sequences in murine and feline leukemia retroviruses. J Virol 69:1353-8
Nash, M A; Meyer, M K; Decker, G L et al. (1993) A subset of Pr65gag is nucleus associated in murine leukemia virus-infected cells. J Virol 67:1350-6
Wied, G L; Dytch, H E (1990) The cytomorphologic and cytometric manifestations of cervical reparative processes. Ann Ostet Ginecol Med Perinat 111:349-63
Hamelin, R; Honore, N; Sergiescu, D et al. (1990) Reversion of thermosensitive splicing defect of Moloney murine sarcoma virus ts110 by oversplicing of viral RNA. J Virol 64:1378-82